Abstract
Extracellular vesicles (EVs) are nano-sized, cell-released vesicles which contain lipids, proteins, and nucleic acids derived from the parental cells. EVs play an important role in intercellular communication and influence both physiological and pathological conditions. They are increasingly explored as potential therapeutic agents since they can cross biological barriers, their cargo is protected from degradation and they are involved in the transfer of bioactive components. EVs can promote tissue regeneration and might be alternatives to cell therapy. They can be used both in their native form, and as delivery vehicles for therapeutic agents. However, there are many hurdles to overcome for broad clinical application of EVs as therapeutics. Here, we review recent conditions regarding EVs therapeutics in regenerative medicine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- EV:
-
Extracellular vesicle
- MSC:
-
Mesenchymal stromal cell
- CNS:
-
Central nervous system
- GvHD:
-
Graft versus host disease
- iPSC:
-
Induced pluripotent stem cell
- SEC:
-
Size-exclusion chromatography
References
Álvarez-Viejo M (2020) Mesenchymal stem cells from different sources and their derived exosomes: a pre-clinical perspective. World J Stem Cells 12:100–109
Aminzadeh MA et al (2015) Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy. Eur Heart J 36:751–762
Arntz OJ et al (2015) Oral administration of bovine milk derived extracellular vesicles attenuates arthritis in two mouse models. Mol Nutr Food Res 59:1701–1712
Ban JJ, Lee M, Im W, Kim M (2015) Low pH increases the yield of exosome isolation. Biochem Biophys Res Commun 461:76–79
Batrakova EV, Kim MS, Hill C (2016) Using exosomes, naturally-equipped nanocarriers, for drug delivery:396–405. https://doi.org/10.1016/j.jconrel.2015.07.030.Using
Caplan AI, Correa D (2011) The MSC: an injury drugstore. Cell Stem Cell 9(1):11–15. https://doi.org/10.1016/j.stem.2011.06.008
Caplan AI, Manuscript A (2012) The MSC: an injury drugstore. Cell Stem Cell 9:11–15
Chen TS et al (2011) Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. J Transl Med 9:47
Galipeau J, Sensébé L (2018) Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell 22:824–833
Ge Q et al (2014) MiRNA in plasma exosome is stable under different storage conditions. Molecules 19:1568–1575
Guo S et al (2019) Intranasal delivery of mesenchymal stem cell derived exosomes loaded with phosphatase and Tensin homolog siRNA repairs complete spinal cord injury. ACS Nano 13:10015–10028
Gutierrez-Aranda I et al (2010) Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection. Stem Cells 28:1568–1570
Hergenreider E et al (2012) Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14:249–256
Imai T et al (2015) Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice. 1:1–8
Ju S et al (2013) Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. Mol Ther 21:1345–1357
Kordelas L et al (2014) MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 28:970–973
Lai RC et al (2010) Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4:214–222
Luarte A, Bátiz LF, Wyneken U, Lafourcade C (2016) Potential therapies by stem cell-derived exosomes in CNS diseases: focusing on the neurogenic niche. Stem Cells Int 2016
Monsel A et al (2015) Therapeutic effects of human mesenchymal stem cell-derived microvesicles in severe pneumonia in mice. Am J Respir Crit Care Med 192:324–336
Nassar W et al (2016) Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases. Biomater Res 20:1–11
Ning H et al (2008) The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia 22:593–599
Posch A (2015) A protocol for exosome isolation and characterization. 1295
Rutering J et al (2016) Exosomes as drug delivery vehicles for Parkinson’s disease therapy 5:1–8
Sjöqvist S et al (2019) Exosomes derived from clinical-grade oral mucosal epithelial cell sheets promote wound healing. J Extracell Vesicles 8:1565264
Sjoqvist S et al (2019) Oral keratinocyte-derived exosomes regulate proliferation of fibroblasts and epithelial cells. Biochem Biophys Res Commun 514:706–712
Squillaro T, Peluso G, Galderisi U (2016) Review clinical trials with mesenchymal stem cells : an update 25:829–848
Taheri B et al (2019) Induced pluripotent stem cell-derived extracellular vesicles: a novel approach for cell-free regenerative medicine. J Cell Physiol 234:8455–8464
Takahashi Y et al (2013) Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol 165:77–84
Tan JL et al (2018) Amnion epithelial cell-derived exosomes restrict lung injury and enhance endogenous lung repair. Stem Cells Transl Med. https://doi.org/10.1002/sctm.17-0185
Théry C et al (2018) Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7
Tögel F, Hu Z, Weiss K (2005) Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol 84148:31–42
Vrijsen KR et al (2016) Exosomes from cardiomyocyte progenitor cells and mesenchymal stem cells stimulate angiogenesis via EMMPRIN. Adv Healthc Mater 5:2555–2565
Watson DC et al (2016) Biomaterials Ef fi cient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials 105:195–205
Wiklander OPB (2015) Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. 1:1–13
Wiklander OPB, Brennan MÁ, Lötvall J, Breakefield XO, El Andaloussi S (2019) Advances in therapeutic applications of extracellular vesicles. Sci Transl Med 11:eaav8521
Witwer KW et al (2013) Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell vesicles 2:1–25
Wolf P (1989) The nature and significance of platelet products in human plasma. Connect Tissue Res 23:123–136
Xing, Z., Zhao, C., Liu, H. & Fan, Y. Endothelial progenitor cell-derived extracellular vesicles : a novel candidate for regenerative medicine and disease treatment. 2000255, (2020)
Yamashita T, Takahashi Y, Takakura Y (2018) Possibility of exosome-based therapeutics and challenges in production of exosomes eligible for therapeutic application. Biol Pharm Bull 41:835–842
Zhang J et al (2015) Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis. J Transl Med 13:49
Zhang Y et al (2019) Embryonic stem cell-derived extracellular vesicles enhance the therapeutic effect of mesenchymal stem cells. Theranostics 9:6976–6990
Zhang B, Tian X, Hao J, Xu G, Zhang W (2020) Mesenchymal stem cell-derived extracellular vesicles in tissue regeneration. Cell Transplant 29:1–14
Zhao Y et al (2014) GDNF-transfected macrophages produce potent neuroprotective effects in parkinson’s disease mouse model. PLoS One 9:1–11
Zhuang X et al (2011) Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 19:1769–1779
Disclosure Statement
Aya Imafuku and Sebastian Sjoqvist are founders and owners of ExTherea Inc., Kanagawa, Japan. Sebastian Sjoqvist is employed by Takeda Pharmaceuticals.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Imafuku, A., Sjoqvist, S. (2020). Extracellular Vesicle Therapeutics in Regenerative Medicine. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 11. Advances in Experimental Medicine and Biology(), vol 1312. Springer, Cham. https://doi.org/10.1007/5584_2020_599
Download citation
DOI: https://doi.org/10.1007/5584_2020_599
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-71924-1
Online ISBN: 978-3-030-71925-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)